The 2nd international congress on research of rare and orphan diseases at the Gehry building on the Novartis Campus in Basel, Switzerland, from 5th to 8th March 2014 was a great success.
The conference sessions explored issues and cutting-edge technologies that affect many adult and paediatric conditions. The following topics were discussed:
- Stem cell and cell therapy approaches
- Mapping diseases and genome instability
- Pathophysiology and diagnostics
- Bringing treatments to the clinic
- Degenerative disorders
- Patients and Research
To pursue the scientific discussions and knowledge sharing, the BLACKSWAN Foundation launched the online RE(ACT) Community: a human network to share information and boost research through crowdfunding on rare and orphan diseases.
|Our aim is to promote research on rare and orphan diseases among the general public, industry and policymakers as well as to provide a forum for researchers to meet and pool their knowledge. The underlying objective is to tackle the key issues that need to be addressed if we are to see new and promising therapies and treatments rapidly delivered to patients all around the world. This will also help to further understanding of other more common diseases and to encourage clear insights from the scientific community in universities and industry.The congress brought together world leaders and young scientists from stem cell, cell biology, gene therapy, human genetic, or therapeutic applications to present state-of-the-art research, to discuss results and to exchange ideas. We look forward to the next edition in 2016.|
Find the photos of the RE(ACT) Congress 2014Â here
Download the Abstract Brochure 2014 here
CONTINUALÂ MEDICAL EDUCATION:
The conference has been accredited by the Swiss Society of Medical Genetics for a maximumÂ of 18 CME credits.